Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.

Qiuyuan WenYuting ZhanHongmei ZhengHongjing ZangJiadi LuoYuting ZhangWeiyuan WangJuan FengJunmi LuLingjiao ChenSongqing Fan

Published in: Diagnostic pathology (2019)

Elevated expression of Mcl-1 might be inversely proportional to disease progression of NSCLC patients by promoting cell proliferation and inhibiting apoptosis, and Mcl-1 might serve as novel biomarker of poor prognosis for NSCLC patients.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
ejection fraction
small cell lung cancer
cell proliferation
newly diagnosed
oxidative stress
peritoneal dialysis
endoplasmic reticulum stress
cell death
lymph node